Evidence map›Paper›PMID 35311127›Full record

ArticleFrontiers in oncology2022

Deep Learning Model for Intracranial Hemangiopericytoma and Meningioma Classification.

Ziyan Chen, Ningrong Ye, Nian Jiang, Qi Yang, Siyi Wanggou, Xuejun Li

Abstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Preoperative diagnosis of meningioma sinus invasion based on MRI radiomics and deep learning: a multicenter study.Cancer imaging : the official publication of the International Cancer Imaging Society · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ziyan ChenDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Ningrong YeDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Nian JiangDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Qi YangDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Siyi WanggouDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Xuejun LiDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Intracranial hemangiopericytoma/solitary fibrous tumor (SFT/HPC) is a rare type of neoplasm containing malignancies of infiltration, peritumoral edema, bleeding, or bone destruction. However, SFT/HPC has similar radiological characteristics as meningioma, which had different clinical managements and outcomes. This study aims to discriminate SFT/HPC and meningioma Methods: We enrolled 236 patients with histopathological diagnosis of SFT/HPC (n = 144) and meningioma (n = 122) from 2010 to 2020 in Xiangya Hospital. Radiological features were extracted manually, and a radiological diagnostic model was applied for classification. And a deep learning pretrained model ResNet-50 was adapted to train T1-contrast images for predicting tumor class. Deep learning model attention mechanism was visualized by class activation maps. Results: Our study reports that SFT/HPC was found to have more invasion to venous sinus (

Indexed as

classificationdeep learninghemangiopericytomamagnetic resonance imagingmeningioma

Identifiers

PMID35311127
PMCPMC8927090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.